Colorectal cancer screening, version 1.2015: Featured updates to the NCCN guidelines

JNCCN Journal of the National Comprehensive Cancer Network

Volumn 13, Issue 8, 2015, Pages 959-968

  Provenzale, Dawn ^a   Jasperson, Kory ^b   Ahnen, Dennis J ^c   Aslanian, Harry ^d   Bray, Travis ^e   Cannon, Jamie A ^f   David, Donald S ^g   Early, Dayna S ^h   Erwin, Deborah ⁱ   Ford, James M ^j   Giardiello, Francis M ^k   Gupta, Samir ^l   Halverson, Amy L ^m   Hamilton, Stanley R ⁿ   Hampel, Heather ^o   Ismail, Mohammad K ^p   Klapman, Jason B ^q   Larson, David W ^r   Lazenby, Audrey J ^s   Lynch, Patrick M ⁿ   Mayer, Robert J ^t   Ness, Reid M ^u   Rao, M Sambasiva ^m   Regenbogen, Scott E ^v   Shike, Moshe ^w   Steinbach, Gideon ^x   Weinberg, David ^y   Dwyer, Mary A ^z   Freedman Cass, Deborah A ^z   Darlow, Susan ^z   more..

^a DUKE CANCER INSTITUTE   (United States)

^b UNIVERSITY OF UTAH   (United States)

^c University of Colorado Cancer Center   (United States)

^d YALE CANCER CENTER   (United States)

^e Hereditary Colon Cancer Foundation   (United States)

^f UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^g CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

^h BARNES JEWISH HOSPITAL   (United States)

ⁱ ROSWELL PARK CANCER INSTITUTE   (United States)

^j STANFORD CANCER INSTITUTE   (United States)

^k JOHNS HOPKINS UNIVERSITY   (United States)

^l UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^m NORTHWESTERN UNIVERSITY   (United States)

ⁿ UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^o OHIO STATE UNIVERSITY   (United States)

^p UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^q H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

^r MAYO CLINIC CANCER CENTER   (United States)

^s UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^t Dana Farber Brigham and Women's Cancer Center   (United States)

^u VANDERBILT INGRAM CANCER CENTER   (United States)

^v UNIVERSITY OF MICHIGAN COMPREHENSIVE CANCER CENTER   (United States)

^w MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^x USA   (United States)

^y FOX CHASE CANCER CENTER   (United States)

^z National Comprehensive Cancer Network   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

GUAIAC;

ACCREDITATION; ARTICLE; CANCER SCREENING; CLINICAL TRIAL (TOPIC); COLON POLYP; COLONOSCOPY; COLORECTAL CANCER; COMPUTED TOMOGRAPHIC COLONOGRAPHY; CONTINUING EDUCATION; DNA DETERMINATION; EVALUATION AND FOLLOW UP; FAMILY HISTORY; FECES ANALYSIS; HUMAN; IMMUNOCHEMISTRY; INTESTINE PREPARATION; OCCULT BLOOD; PRACTICE GUIDELINE; SIGMOIDOSCOPY; COLORECTAL NEOPLASMS; EARLY CANCER DIAGNOSIS; MORTALITY; PROCEDURES; RISK FACTOR;

COLORECTAL NEOPLASMS; EARLY DETECTION OF CANCER; HUMANS; RISK FACTORS;

EID: 84940101079     PISSN: 15401405     EISSN: 15401413     Source Type: Journal    
DOI: 10.6004/jnccn.2015.0116     Document Type: Article

References (61)

1. Siegel RL, Miller KD, Jemal A. Cancer statistics, 2015. CA Cancer J Clin 2015;65:5-29.
2. Levin B, Lieberman DA, McFarland B, et al. Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: a joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology. CA Cancer J Clin 2008;58:130-160.
3. Rex DK, Johnson DA, Anderson JC, et al. American College of Gastroenterology guidelines for colorectal cancer screening 2009 [corrected]. Am J Gastroenterol 2009;104:739-750.
4. USPSTF. Screening for colorectal cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med 2008;149:627-637.
5. Siegel R, Desantis C, Jemal A. Colorectal cancer statistics, 2014. CA Cancer J Clin 2014;64:104-117.
6. Burt R, Neklason D.W. Genetic testing for inherited colon cancer. Gastroenterology 2005;128:1696-1716.
7. Giardiello FM, Offerhaus J.G. Phenotype and cancer risk of various polyposis syndromes. Eur J Cancer 1995;31A:1085-1087.
8. Hamilton SR, Liu B, Parsons RE, et al. The molecular basis of Turcot's syndrome. N Engl J Med 1995;332:839-847.
9. Siegel R, Ward E, Brawley O, Jemal A. Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths. CA Cancer J Clin 2011;61:212-236.
10. Meester RG, Doubeni CA, Lansdorp-Vogelaar I, et al. Colorectal cancer deaths attributable to nonuse of screening in the United States. Ann Epidemiol 2015;25:208-213.e1.
11. Cancer screening-United States, 2010. MMWR Morb Mortal Wkly Rep 2012;61:41-45.
12. Meester RG, Doubeni CA, Zauber AG, et al. Public health impact of achieving 80% colorectal cancer screening rates in the United States by 2018 [published online ahead of print]. Cancer, doi: 10.1002/cncr.29336.
13. Nishihara R, Wu K, Lochhead P, et al. Long-term colorectal-cancer incidence and mortality after lower endoscopy. N Engl J Med 2013;369:1095-1105.
14. Atkin WS, Edwards R, Kralj-Hans I, et al. Once-only flexible sigmoidoscopy screening in prevention of colorectal cancer: a multicentre randomised controlled trial. Lancet 2010;375:1624-1633.
15. Schoen RE, Pinsky PF, Weissfeld JL, et al. Colorectal-cancer incidence and mortality with screening flexible sigmoidoscopy. N Engl J Med 2012;366:2345-2357.
16. Hoff G, Grotmol T, Skovlund E, Bretthauer M. Risk of colorectal cancer seven years after flexible sigmoidoscopy screening: randomised controlled trial. BMJ 2009;338:b1846.
17. Segnan N, Armaroli P, Bonelli L, et al. Once-only sigmoidoscopy in colorectal cancer screening: follow-up findings of the Italian Randomized Controlled Trial-SCORE. J Natl Cancer Inst 2011;103:1310-1322.
18. Holme O, Loberg M, Kalager M, et al. Effect of flexible sigmoidoscopy screening on colorectal cancer incidence and mortality: a randomized clinical trial. JAMA 2014;312:606-615.
19. Brenner H, Stock C, Hoffmeister M. Effect of screening sigmoidoscopy and screening colonoscopy on colorectal cancer incidence and mortality: systematic review and meta-analysis of randomised controlled trials and observational studies. BMJ 2014;348:g2467.
20. Elmunzer BJ, Hayward RA, Schoenfeld PS, et al. Effect of flexible sigmoidoscopy-based screening on incidence and mortality of colorectal cancer: a systematic review and meta-analysis of randomized controlled trials. PLoS Med 2012;9:e1001352.
21. Holme O, Bretthauer M, Fretheim A, et al. Flexible sigmoidoscopy versus faecal occult blood testing for colorectal cancer screening in asymptomatic individuals. Cochrane Database Syst Rev 2013;9:CD009259.
22. Shroff J, Thosani N, Batra S, et al. Reduced incidence and mortality from colorectal cancer with flexible-sigmoidoscopy screening: a meta-analysis. World J Gastroenterol 2014;20:18466-18476.
23. Burt R.W. Colorectal cancer screening. Curr Opin Gastroenterol 2010;26:466-470.
24. Brenner H, Chang-Claude J, Seiler CM, et al. Protection from colorectal cancer after colonoscopy: a population-based, case-control study. Ann Intern Med 2011;154:22-30.
25. Brenner H, Chang-Claude J, Jansen L, et al. Reduced risk of colorectal cancer up to 10 years after screening, surveillance, or diagnostic colonoscopy. Gastroenterology 2014;146:709-717.
26. Citarda F, Tomaselli G, Capocaccia R, et al. Efficacy in standard clinical practice of colonoscopic polypectomy in reducing colorectal cancer incidence. Gut 2001;48:812-815.
27. Jacob BJ, Moineddin R, Sutradhar R, et al. Effect of colonoscopy on colorectal cancer incidence and mortality: an instrumental variable analysis. Gastrointest Endosc 2012;76:355-364.e1.
28. Kahi CJ, Imperiale TF, Juliar BE, Rex D.K. Effect of screening colonoscopy on colorectal cancer incidence and mortality. Clin Gastroenterol Hepatol 2009;7:770-775; quiz 711.
29. Winawer SJ, Zauber AG, Ho MN, et al. Prevention of colorectal cancer by colonoscopic polypectomy. The National Polyp Study Workgroup. N Engl J Med 1993;329:1977-1981.
30. Manser CN, Bachmann LM, Brunner J, et al. Colonoscopy screening markedly reduces the occurrence of colon carcinomas and carcinoma-related death: a closed cohort study. Gastrointest Endosc 2012;76:110-117.
31. Morois S, Cottet V, Racine A, et al. Colonoscopy reduced distal colorectal cancer risk and excess cancer risk associated with family history. Cancer Causes Control 2014;25:1329-1336.
32. Muller AD, Sonnenberg A. Prevention of colorectal cancer by flexible endoscopy and polypectomy. A case-control study of 32,702 veterans. Ann Intern Med 1995;123:904-910.
33. Rabeneck L, Paszat LF, Saskin R, Stukel T.A. Association between colonoscopy rates and colorectal cancer mortality. Am J Gastroenterol 2010;105:1627-1632.
34. Amri R, Bordeianou LG, Sylla P, Berger D.L. Impact of screening colonoscopy on outcomes in colon cancer surgery. JAMA Surg 2013;148:747-754.
35. Johnson DA, Barkun AN, Cohen LB, et al. Optimizing adequacy of bowel cleansing for colonoscopy: recommendations from the US multi-society task force on colorectal cancer. Gastroenterology 2014;147:903-924.
36. Enestvedt BK, Tofani C, Laine LA, et al. 4-Liter split-dose polyethylene glycol is superior to other bowel preparations, based on systematic review and meta-analysis. Clin Gastroenterol Hepatol 2012;10:1225-1231.
37. Gurudu SR, Ramirez FC, Harrison ME, et al. Increased adenoma detection rate with system-wide implementation of a split-dose preparation for colonoscopy. Gastrointest Endosc 2012;76:603-608.e1.
38. Kilgore TW, Abdinoor AA, Szary NM, et al. Bowel preparation with split-dose polyethylene glycol before colonoscopy: a meta-analysis of randomized controlled trials. Gastrointest Endosc 2011;73:1240-1245.
39. Longcroft-Wheaton G, Bhandari P. Same-day bowel cleansing regimen is superior to a split-dose regimen over 2 days for afternoon colonoscopy: results from a large prospective series. J Clin Gastroenterol 2012;46:57-61.
40. Matro R, Shnitser A, Spodik M, et al. Efficacy of morning-only compared with split-dose polyethylene glycol electrolyte solution for afternoon colonoscopy: a randomized controlled single-blind study. Am J Gastroenterol 2010;105:1954-1961.
41. Varughese S, Kumar AR, George A, Castro F.J. Morning-only one-gallon polyethylene glycol improves bowel cleansing for afternoon colonoscopies: a randomized endoscopist-blinded prospective study. Am J Gastroenterol 2010;105:2368-2374.
42. Kriza C, Emmert M, Wahlster P, et al. An international review of the main cost-effectiveness drivers of virtual colonography versus conventional colonoscopy for colorectal cancer screening: is the tide changing due to adherence? Eur J Radiol 2013;82:e629-636.
43. Kim DH, Pickhardt PJ, Taylor AJ, Menias C.O. Imaging evaluation of complications at optical colonoscopy. Curr Probl Diagn Radiol 2008;37:165-177.
44. Whitlock EP, Lin JS, Liles E, et al. Screening for colorectal cancer: a targeted, updated systematic review for the U.S. Preventive Services Task Force. Ann Intern Med 2008;149:638-658.
45. Johnson CD, Chen MH, Toledano AY, et al. Accuracy of CT colonography for detection of large adenomas and cancers. N Engl J Med 2008;359:1207-1217.
46. Halligan S, Altman DG, Taylor SA, et al. CT colonography in the detection of colorectal polyps and cancer: systematic review, meta-analysis, and proposed minimum data set for study level reporting. Radiology 2005;237:893-904.
47. Mulhall BP, Veerappan GR, Jackson J.L. Meta-analysis: computed tomographic colonography. Ann Intern Med 2005;142:635-650.
48. Togashi K, Utano K, Kijima S, et al. Laterally spreading tumors: limitations of computed tomography colonography. World J Gastroenterol 2014;20:17552-17557.
49. Hardcastle JD, Chamberlain JO, Robinson MH, et al. Randomised controlled trial of faecal-occult-blood screening for colorectal cancer. Lancet 1996;348:1472-1477.
50. Kronborg O, Fenger C, Olsen J, et al. Randomised study of screening for colorectal cancer with faecal-occult-blood test. Lancet 1996;348:1467-1471.
51. Mandel JS, Bond JH, Church TR, et al. Reducing mortality from colorectal cancer by screening for fecal occult blood. Minnesota Colon Cancer Control Study. N Engl J Med 1993;328:1365-1371.
52. Osborn NK, Ahlquist D.A. Stool screening for colorectal cancer: molecular approaches. Gastroenterology 2005;128:192-206.
53. Ahlquist DA, Sargent DJ, Loprinzi CL, et al. Stool DNA and occult blood testing for screen detection of colorectal neoplasia. Ann Intern Med 2008;149:441-450, W481.
54. Ahlquist DA, Zou H, Domanico M, et al. Next-generation stool DNA test accurately detects colorectal cancer and large adenomas. Gastroenterology 2012;142:248-256; quiz e225-246.
55. Imperiale TF, Ransohoff DF, Itzkowitz SH, et al. Multitarget stool DNA testing for colorectal-cancer screening. N Engl J Med 2014;370:1287-1297.
56. Ned RM, Melillo S, Marrone M. Fecal DNA testing for colorectal cancer screening: the ColoSure test. PLoS Curr 2011;3:RRN1220.
57. Taylor DP, Burt RW, Williams MS, et al. Population-based family history-specific risks for colorectal cancer: a constellation approach. Gastroenterology 2010;138:877-885.
58. Taylor DP, Stoddard GJ, Burt RW, et al. How well does family history predict who will get colorectal cancer? Implications for cancer screening and counseling. Genet Med 2011;13:385-391.
59. Samadder NJ, Curtin K, Tuohy TM, et al. Increased risk of colorectal neoplasia among family members of patients with colorectal cancer: a population-based study in Utah. Gastroenterology 2014;147:814-821.e5; quiz e815-816.
60. Imperiale TF, Ransohoff D.F. Risk for colorectal cancer in persons with a family history of adenomatous polyps: a systematic review. Ann Intern Med 2012;156:703-709.
61. Tuohy TM, Rowe KG, Mineau GP, et al. Risk of colorectal cancer and adenomas in the families of patients with adenomas: a population-based study in Utah. Cancer 2014;120:35-42.